Study of the Effect of Transcranial Stimulations in Aphasic Subject Within a Year of Their Stroke

NCT ID: NCT02101398

Last Updated: 2025-09-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

5 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-10-02

Study Completion Date

2016-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this work is to study the effect of transcranial direct current stimulation combined with naming therapy in acute and post-acute stroke comparing four bihemispheric positioning electrodes to a sham condition.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

TDCS have shown a positive effect on clinical outcome in naming treatment in aphasic subjects however some aspects as the positioning of the electrodes on the head are still unclear. That is why we compare the effects of four different positionings of the electrodes (two anterior over Broca's area and its homologue and two posterior over Wernicke's area and its homologue) to a sham stimulation in order to observe if a more important effect of one or another positioning could be found.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Aphasia Stroke

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Caregivers

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

F7A

Anodal electrode set on the left Broca's area and cathodal electrode set on its right homologue. Active stimulation.

Group Type EXPERIMENTAL

eldith DC-stimulator, configuration F7A

Intervention Type DEVICE

tDCS will be delivered during a 20 minutes speech-language therapy session

F7C

Cathodal electrode set on the left Broca's area and anodal electrode set on its right homologue. Active stimulation.

Group Type EXPERIMENTAL

eldith DC-stimulator, configuration F7C

Intervention Type DEVICE

tDCS will be delivered during a 20 minutes speech-language therapy session

T5A

Anodal electrode set on the left Wernicke's area and cathodal electrode set on its right homologue. Active stimulation.

Group Type EXPERIMENTAL

eldith DC-stimulator, configuration T5A

Intervention Type DEVICE

tDCS will be delivered during a 20 minutes speech-language therapy session

T5C

Cathodal electrode set on the left Wernicke's area and anodal electrode set on its right homologue. Active stimulation.

Group Type EXPERIMENTAL

eldith DC-stimulator, configuration T5C

Intervention Type DEVICE

tDCS will be delivered during a 20 minutes speech-language therapy session

Sham

Electrodes set on the left Broca's area and its right homologue or electrodes set on the left Wernicke's area and its right homologue, but no stimulation will be delivered.

Group Type SHAM_COMPARATOR

eldith DC-stimulator, configuration Sham

Intervention Type DEVICE

Sham tDCS will be delivered during a 20 minutes speech-language therapy session

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

eldith DC-stimulator, configuration F7A

tDCS will be delivered during a 20 minutes speech-language therapy session

Intervention Type DEVICE

eldith DC-stimulator, configuration F7C

tDCS will be delivered during a 20 minutes speech-language therapy session

Intervention Type DEVICE

eldith DC-stimulator, configuration T5A

tDCS will be delivered during a 20 minutes speech-language therapy session

Intervention Type DEVICE

eldith DC-stimulator, configuration T5C

tDCS will be delivered during a 20 minutes speech-language therapy session

Intervention Type DEVICE

eldith DC-stimulator, configuration Sham

Sham tDCS will be delivered during a 20 minutes speech-language therapy session

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* man or woman of 18 years and older
* aphasic patient following a first left hemispheric stroke
* BDAE 3.0 aphasia score \> or = to 1
* stroke within 3 to 12 months before inclusion in the study
* mother tongue = French
* right handedness
* signed informed consent

Exclusion Criteria

* history of other neurologic pathologies
* epileptic seizure within 2 months before inclusion
* dementia
* bilingual patient (2 mother tongues)
* history of cranial surgery
* presence of intracerebral metallic material
* unauthorized molecules at inclusion : sulpiride, rivastigmine, dextromethorphan, carbamazepine, flunarizine, levodopa
* pregnant, parturient or lactating woman
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nicolas ROCHE, MD

Role: PRINCIPAL_INVESTIGATOR

Hôpital Raymond Poincaré

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hôpital Raymond Poincaré

Garches, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2013-A00989-36

Identifier Type: REGISTRY

Identifier Source: secondary_id

C12-09

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

TDCS in Acute Stroke
NCT01701713 UNKNOWN NA
Evaluating Anodal tDCS Preceding Aphasia Therapy
NCT02249819 TERMINATED PHASE1/PHASE2